We are live on
!
Find out more
Wealth Enhancement Advisory Services Portfolio holdings
AUM
$59.8B
1-Year Est. Return
29.42%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+29.42%
3 Year Est. Return
+77.06%
5 Year Est. Return
+66.38%
10 Year Est. Return
+178.95%
AUM
$60.5B
AUM Growth
+$8.17B
(+16%)
Cap. Flow
+$3.47B
Cap. Flow
% of AUM
5.74%
Top 10 Holdings %
Top 10 Hldgs %
23.65%
Holding
3,520
New
510
Increased
1,636
Reduced
1,103
Closed
162
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JMTG
JPMorgan Mortgage-Backed Securities ETF
JMTG
|
+$141M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$128M |
| 3 |
ALPS Smith Core Plus Bond ETF
SMTH
|
+$125M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$117M |
| 5 |
Apple
AAPL
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$131M |
| 2 |
JPMorgan Short Duration Core Plus ETF
JSCP
|
+$77.9M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$62.1M |
| 4 |
UnitedHealth
UNH
|
+$35.8M |
| 5 |
CBRE Group
CBRE
|
+$32.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.75% |
| 2 | Financials | 6.58% |
| 3 | Industrials | 4.51% |
| 4 | Consumer Discretionary | 3.84% |
| 5 | Healthcare | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRDL
3276
Cardiol Therapeutics
CRDL
$164M
| $25.9K | ﹤0.01% |
+16,840
| New | +$19.6K |
|
3277
ChargePoint
CHPT
$161M
| $25.7K | ﹤0.01% |
1,794
-7,188
| -80% | -$96.3K |
|
|
NAK
3278
Northern Dynasty Minerals
NAK
$958M
| $25.6K | ﹤0.01% |
18,320
+5,000
| +38% | +$5.58K |
|
3279
Neumora Therapeutics
NMRA
$302M
| $24.5K | ﹤0.01% |
29,820
+13,862
| +87% | +$10.5K |
|
3280
PUT
Invesco QQQ Trust
QQQ
$481B
| $23.9K | ﹤0.01% |
10,000
+600
| +6% | +$298K |
|
3281
Tenaya Therapeutics
TNYA
$163M
| $23.7K | ﹤0.01% |
38,722
-19,825
| -34% | -$10.1K |
|
|
URG
3282
Ur-Energy
URG
$556M
| $22.9K | ﹤0.01% |
+21,039
| New | +$16.8K |
|
|
OPTU
3283
Optimum Communications Inc
OPTU
$301M
| $22.5K | ﹤0.01% |
+10,144
| New | +$23.8K |
|
3284
PUT
EQT Corp
EQT
$32.3B
| $22.4K | ﹤0.01% |
11,900
-1,400
| -11% | -$75.5K |
|
3285
Allogene Therapeutics
ALLO
$694M
| $22.3K | ﹤0.01% |
18,736
-524
| -3% | -$696 |
|
3286
Destination XL Group
DXLG
$35.4M
| $22.2K | ﹤0.01% |
18,480
+20
| +0.1% | +$22 |
|
3287
DocGo
DCGO
$62.6M
| $22.1K | ﹤0.01% |
+13,969
| New | +$26K |
|
|
CAN
3288
Canaan Creative
CAN
$159M
| $21.1K | ﹤0.01% |
+30,000
| New | +$21.1K |
|
3289
GrafTech
EAF
$212M
| $20.6K | ﹤0.01% |
1,985
-462
| -19% | -$4.09K |
|
3290
DarioHealth
DRIO
$71.2M
| $19.9K | ﹤0.01% |
+1,413
| New | +$19.6K |
|
3291
CALL
Invesco Solar ETF
TAN
$1.38B
| $19.8K | ﹤0.01% |
+12,000
| New | +$377K |
|
3292
Getty Images
GETY
$183M
| $19.5K | ﹤0.01% |
+10,781
| New | +$19K |
|
3293
Incannex Healthcare
IXHL
$37.7M
| $19.2K | ﹤0.01% |
+3,049
| New | +$30.1K |
|
3294
BARK
BARK
$101M
| $18.8K | ﹤0.01% |
+1,030
| New | +$23.7K |
|
|
ESPR
3295
DELISTED
Esperion Therapeutics
ESPR
| $18.2K | ﹤0.01% |
+15,522
| New | +$15.5K |
|
3296
PUT
Bank of Montreal
BMO
$127B
| $18.1K | ﹤0.01% |
25,600
-3,000
| -10% | -$302K |
|
3297
ALX Oncology
ALXO
$290M
| $18.1K | ﹤0.01% |
39,279
-1,272
| -3% | -$642 |
|
3298
Polestar Automotive Holding UK
PSNY
$2.06B
| $18K | ﹤0.01% |
536
+65
| +14% | +$2.06K |
|
3299
SKYX Platforms
SKYX
$164M
| $17.9K | ﹤0.01% |
15,946
-15,946
| -50% | -$19.2K |
|
3300
Ocugen
OCGN
$434M
| $16.3K | ﹤0.01% |
17,083
+2,246
| +15% | +$1.86K |
|
Similar funds
QCM
NAMI
Wealth Enhancement Advisory Services's Q2 2025 Portfolio in Review
As of Q2 2025, Wealth Enhancement Advisory Services held 3,520 positions worth $60.5B, up 16% from $52.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Wealth Enhancement Advisory Services deployed $3.47B of net new capital in Q2 2025, opening 510 new positions and adding to 1,636 existing holdings. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 2,815,302 shares worth $141M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Palantir, an estimated $131M trimmed.
- Wealth Enhancement Advisory Services's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 2,815,302 shares worth $141M.
- Wealth Enhancement Advisory Services added most to iShares Core US Aggregate Bond ETF in Q2 2025, an estimated $128M increase.
- Wealth Enhancement Advisory Services's biggest Q2 2025 reduction was Palantir, cutting an estimated $131M.
- Wealth Enhancement Advisory Services fully exited Discover Financial Services in Q2 2025, selling an estimated $10.8M.
- Wealth Enhancement Advisory Services's ten largest holdings make up 24% of its $60.5B portfolio in Q2 2025.
- Wealth Enhancement Advisory Services opened 510 new positions and closed 162 in Q2 2025.
- Wealth Enhancement Advisory Services's portfolio value rose 16% quarter-over-quarter to $60.5B.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2025, filed 10 Jul 2025.